Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

US Pharmacopeia in 2026: USP–NF Standards, Monographs, General Chapters, and Pharmaceutical Compliance

Explore how USP-NF standards, monographs, General Chapters, and reference standards support pharmaceutical quality testing and GMP compliance. Learn which compendial requirements are mandatory, how teams manage updates, and what evidence laboratories should maintain for inspection readiness.
  • Blog, Quality Management System
Pharmaceutical quality laboratory applying USP monographs, reference standards, analytical testing, and GMP compliance controls.

Pharmaceutical QMS Software in 2026: eQMS Features, Compliance, and Validation

Explore how an electronic quality management system strengthens CAPA management, document control, audit trail review, and computerized system validation. This guide explains the core eQMS controls pharmaceutical companies need to maintain GMP compliance and improve inspection readiness.
  • Blog, Computerized System Validation
eQMS software for pharma dashboard supporting CAPA management, computerized system validation, audit trail review, and GMP inspection readiness.

FDA Quietly Rewrites Drug Repurposing Rules; Pharma Data Validation Suddenly Becomes Critical

The FDA is urging pharmaceutical companies to re-examine decades of clinical and real-world data using AI and advanced analytics to identify new uses for existing drugs. Published on May 29, 2026, this initiative highlights how legacy datasets may still hold
  • News
FDA Quietly Rewrites Drug Repurposing Rules; Pharma Data Validation Suddenly Becomes Critical